Healthcare Analytical Testing Services Market Set To Grow From $8.7 Billion In 2026 To $14.64 Billion By 2030 At A CAGR Of 13.9%
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Healthcare Analytical Testing Services Market Forecast: What Market Value Is Expected By 2030?
The sector for healthcare analytical testing services has experienced substantial expansion lately and is projected to continue its upward trajectory. Following its valuation at $7.6 billion in 2025, this market is anticipated to reach $8.7 billion by 2026, demonstrating a compound annual growth rate of 14.6%. Key factors contributing to this growth during the preceding period include heightened research and development efforts within the pharmaceutical industry, the increasing intricacy of biological medications, a wider adoption of contract research organizations, more stringent regulatory testing mandates, and a greater emphasis placed on upholding quality assurance standards.
The domain of healthcare analytical testing services is poised for substantial expansion in the upcoming years, projecting a market valuation of $14.64 billion by the year 2030. This growth trajectory is underpinned by a compound annual growth rate of 13.9%, propelled by several key factors including the escalating integration of AI-powered laboratory analytics, a heightened need for high-volume testing solutions, the progressive development of personalized medicine, an intensified emphasis on swift microbial identification, and a discernible trend towards outsourcing analytical validation processes. Furthermore, prominent developments anticipated during this forecast period encompass a greater need for sophisticated bioanalytical examinations, the wider implementation of automated laboratory infrastructures, a stronger concentration on validation services that adhere to regulatory standards, the continued growth of outsourced analytical testing capabilities, and a more profound integration of digital laboratory platforms.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7448&type=smp
Healthcare Analytical Testing Services Market Industry Drivers: What Is Driving Revenue Growth?
The expansion of the healthcare analytical testing services market is anticipated to be propelled by a growing volume of clinical trials. These research endeavors, involving human subjects, are designed to meticulously assess the safety profiles and therapeutic effectiveness of various medical treatments and interventions. The heightened activity in clinical trials stems largely from the escalating incidence of both chronic and uncommon illnesses, which in turn fuels a persistent need for innovative and potent therapeutic solutions. Analytical testing services within the healthcare sector play a crucial role in these trials, contributing to the evaluation of drug safety, efficacy, optimal dosage and formulation, data reliability, and overall quality assurance. Illustratively, the Association of the British Pharmaceutical Industry (ABPI) reported in December 2024 that the United Kingdom witnessed a second consecutive year of growth in the launch of pharmaceutical industry trials, increasing from 411 in the year 2022 to 426 in 2023. Consequently, this upward trend in clinical trials is projected to significantly boost the healthcare analytical testing services market.
Healthcare Analytical Testing Services Market Segmentation Trends And Revenue Drivers
The healthcare analytical testing services market covered in this report is segmented –
1) By Type: Bioanalytical Testing Services, Physical Characterization Services, Method Development And Validation Testing Services, Raw Material Testing Services, Batch-Release Testing Services, Stability Testing, Microbial Testing Services
2) By Application: Drug Discovery And Preclinical Research, Clinical Trials (Phase I–III), Quality Control And Batch-Release Testing, Stability Studies And Shelf-Life Characterization, Regulatory Compliance And Submission Support, Manufacturing Process Support And Troubleshooting, Post-Market Surveillance And Pharmacovigilance Testing
3) By End User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Contract Research Organizations
Subsegments:
1) By Bioanalytical Testing Services: Pharmacokinetics Testing, Biomarker Analysis
2) By Physical Characterization Services: Particle Size Analysis, Surface Area Analysis
3) By Method Development and Validation Testing Services: Analytical Method Development, Method Validation
4) By Raw Material Testing Services: Identity Testing, Purity Testing,
5) By Batch-Release Testing Services: Quality Control Testing, Compliance Testing
6) By Stability Testing: Accelerated Stability Testing, Long-Term Stability Testing
7) By Microbial Testing Services: Sterility Testing, Endotoxin Testing
#Healthcare Analytical Testing Services Market Growth Trends: What Is Influencing The Future Outlook?
Leading entities within the healthcare analytical testing services sector are prioritizing the development of novel offerings, such as extensive bioanalytical capabilities designed to provide all-encompassing assistance throughout the drug development lifecycle, from initial research to advanced clinical phases, encompassing both pharmacokinetic and pharmacodynamic evaluations. This broad bioanalytical coverage signifies a service provider’s capacity to address diverse testing requirements across various molecular entities and drug development stages. As an illustration, in August 2024, SGS Life Science Services SA, a Swiss contract research organization (CRO) renowned for its expertise in analytical development and quality control laboratory services, unveiled a state-of-the-art bioanalytical testing facility. This specialized lab is equipped to quantify drugs, their metabolites, and other biologically significant compounds present in biological specimens, while also providing cell-based assays for cellular biomarkers and high-sensitivity quantification.
Healthcare Analytical Testing Services Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the healthcare analytical testing services market are Almac Group, ALS Limited, Anacura Life Sciences, Charles River Laboratories International Inc., Element Materials Technology Group, Eurofins Scientific SE, ICON plc, Impact Analytical Testing Lab, Intertek Group plc, Pace Analytical Services LLC, PPD Inc., SourceBio International plc, Steris Corporation, Syneos Health Inc., WuXi AppTec, Analytical Bio-Chemistry Laboratories, Avance Biosciences, Avista Pharma Solutions, Avomeen Analytical Services, BioPharma Services Inc., Boston Analytical, Laboratory Corporation, MedPharm Inc., Micro Quality Labs, Microbac Laboratories, Nelson Laboratories LLC, Pacific Biolabs Inc.
Access The Complete Healthcare Analytical Testing Services Market Report:
Healthcare Analytical Testing Services Market Regional Analysis And Leading Geography
North Americawas the largest region in the healthcare analytical testing services market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare analytical testing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
